This educational webinar will give an overview of how CML is treated today and the significance of ’hot topics’ and key treatment development advances published and discussed at 2022 international hematology conferences.
What is new and what does this mean for patients?
We will be joined by:
Prof Andreas Hochhaus, Consultant Haematologist, Director Department of Hematology and Internal Oncology University Hospital Jena, (Germany)
Lisa Machado, Patient Advocate, CML Advocates Network (Canada)
This webinar may be useful for people affected by a diagnosis of CML: patients, family members, supporters and advocates.